Phyto Chem's ₹6.22 cr NCLT claim is 68% of its annual revenue.

Tipsheet Editorial — Fri, 29 May 2026 19:52:31 GMT

The nano-cap reported a net loss of ₹1.80 crore on revenue that fell 36% to ₹9.07 crore. A separate insolvency claim against a debtor now equals two-thirds of its top line.

What’s new

FY26 net loss widened to ₹1.80 cr from ₹0.99 cr a year prior.
Annual revenue dropped 36% to ₹9.07 cr from ₹14.08 cr in FY25.
Phyto Chem has filed a ₹6.22 cr operational claim against Siri Smelters, now in insolvency.

Why it matters

The operational claim against Siri Smelters is not a minor receivable. At ₹6.22 crore, it represents ~68% of Phyto Chem's entire annual revenue and over half of its ₹12 crore market capitalisation. Whether this cash is recoverable is now the central balance-sheet question for a company already burning money.

What we’re watching

The outcome of the NCLT insolvency resolution for Siri Smelters.
How much of the ₹6.22 cr claim the court-appointed professional reconciles.
Whether the operational losses narrow in the new fiscal year.

The full read

Phyto Chem's FY26 numbers are bleak enough on their own: revenue fell 36% to ₹9.07 crore, and the net loss nearly doubled to ₹1.80 crore. But the filing's more important number is ₹6.22 crore. That's the operational claim the nano-cap has filed against Siri Smelters, which NCLT admitted into insolvency in February. The claim is now being reconciled by a court professional, with no guarantee of full recovery. For context, that ₹6.22 crore equals 68% of Phyto Chem's entire year's revenue and more than half its ₹12 crore market capitalisation. The company is shrinking, losing money, and holding a receivable that may be worth a fraction of its face value.

Primary source: BSE · NSE

Phyto Chem plans to lease out factory space to generate rental income

Tipsheet Editorial — Fri, 29 May 2026 19:25:28 GMT

The nano-cap approved FY26 results but the real news is a board discussion about monetizing underused manufacturing space.

What’s new

Board approved audited FY26 results; statutory auditors gave an unmodified opinion.
Management discussed leasing out part of its manufacturing process facility to generate income.
No formal agreement or financial terms for the proposed lease have been finalised.

Why it matters

For a ₹12-crore company, leasing out factory space isn't a sideshow. It's a potential new revenue line that could materially change the income statement if executed. The fact that the board is discussing it, even without a counterparty, signals the current operations aren't using all the capacity it owns.

What we’re watching

Whether the lease proposal turns into a binding agreement with a named tenant.
The financial terms: how much space, at what rent, and over what period.
How the rental income, if any, compares to the company's existing revenue from operations.

The full read

Phyto Chem's board spent Friday signing off on FY26 results, which passed muster with an unmodified auditor's opinion. But the results themselves are the routine part. The company, a ₹12-crore nano-cap, also discussed leasing out part of its manufacturing plant. No tenant, no rent figure, no binding agreement. It is a proposal. Still, the signal is clear: the company has space it isn't using and wants to turn that into cash. For a business this size, even a modest lease could move the needle. The audited numbers are settled. The question is what the board does next with the empty factory floor.

Primary source: BSE · NSE

Phyto Chem (India) Ltd. (PHYTO) — Tipsheet

Phyto Chem's ₹6.22 cr NCLT claim is 68% of its annual revenue.

What’s new

Why it matters

What we’re watching

The full read

Phyto Chem plans to lease out factory space to generate rental income

What’s new

Why it matters

What we’re watching

The full read